Updates of Cancer Hallmarks in Patients With Inborn Errors of Immunity Publisher Pubmed



Wang Y^{1, 2} ; Abolhassani H^{1, 2}
Source: Current Opinion in Allergy and Clinical Immunology Published:2022

Abstract

Purpose of reviewThe development of cancer in patients with genetically determined inborn errors of immunity (IEI) is much higher than in the general population. The hallmarks of cancer are a conceptualization tool that can refine the complexities of cancer development and pathophysiology. Each genetic defect may impose a different pathological tumor predisposition, which needs to be identified and linked with known hallmarks of cancer.Recent findingsFour new hallmarks of cancer have been suggested, recently, including unlocking phenotypic plasticity, senescent cells, nonmutational epigenetic reprogramming, and polymorphic microbiomes. Moreover, more than 50 new IEI genes have been discovered during the last 2 years from which 15 monogenic defects perturb tumor immune surveillance in patients.SummaryThis review provides a more comprehensive and updated overview of all 14 cancer hallmarks in IEI patients and covers aspects of cancer predisposition in novel genes in the ever-increasing field of IEI. © 2022 Lippincott Williams and Wilkins. All rights reserved.